Pentoxifylline combined with mesenchymal stem cells inhibits TGF-β/SMAD signaling pathway and reduces advanced glycation end products aggregation in glomerular mesangial cells induced by high glucose

ZHA Shu-juan, YAN Ji-xi

PDF(3083 KB)
Welcome to Current Immunology, Today is
PDF(3083 KB)
Current Immunology ›› 2020, Vol. 40 ›› Issue (2) : 122-126.

Pentoxifylline combined with mesenchymal stem cells inhibits TGF-β/SMAD signaling pathway and reduces advanced glycation end products aggregation in glomerular mesangial cells induced by high glucose

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2020, 40(2): 122-126

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(3083 KB)

Accesses

Citation

Detail
Sections
Recommended
Contact
Add: 1 / f, library 1, no.280, south chongqing road, Shangha
Code: 200025
Tel: 021-53062055
E-mail: currentimmunol@126.com
visited
Total visitors:
Visitors of today:
Now online:
Copyright © 2022 Current Immunology

/

〈 〉